
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and effectiveness of inactivated vaccines against symptomatic COVID-19, severe COVID-19, and COVID-19 clinical outcomes in the general population: a systematic review and meta-analysis
Martin Law, Sam S.H. Ho, Gigi Kwan Chi Tsang, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 37, pp. 100788-100788
Open Access | Times Cited: 12
Martin Law, Sam S.H. Ho, Gigi Kwan Chi Tsang, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 37, pp. 100788-100788
Open Access | Times Cited: 12
Showing 12 citing articles:
Two centuries of vaccination: historical and conceptual approach and future perspectives
David A. Montero, Roberto Vidal, Juliana Velasco, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 29
David A. Montero, Roberto Vidal, Juliana Velasco, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 29
Shift in SARS-CoV-2 variants of concern from Delta to Omicron was associated with reduced hospitalizations, increased risk of breakthrough infections but lesser disease severity
Fridah Mwendwa, Akbar Kanji, Ali Raza Bukhari, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 6, pp. 1100-1107
Open Access | Times Cited: 3
Fridah Mwendwa, Akbar Kanji, Ali Raza Bukhari, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 6, pp. 1100-1107
Open Access | Times Cited: 3
Multiplex molecular assays for the laboratory-based and point-of-care diagnosis of infections caused by seasonal influenza, COVID-19, and RSV
Alexander Domnich, Elvira Massaro, Giancarlo Icardi, et al.
Expert Review of Molecular Diagnostics (2024), pp. 1-12
Closed Access | Times Cited: 2
Alexander Domnich, Elvira Massaro, Giancarlo Icardi, et al.
Expert Review of Molecular Diagnostics (2024), pp. 1-12
Closed Access | Times Cited: 2
BBIBP-CorV vaccine effectiveness against COVID-19 in patients aged 60 years and older during the Delta-dominant period in the Federation of Bosnia and Herzegovina, a test-negative case-control study
Sanjin Musa, Lore Merdrignac, Siniša Skočibušić, et al.
Vaccine (2024) Vol. 42, Iss. 15, pp. 3467-3473
Open Access | Times Cited: 1
Sanjin Musa, Lore Merdrignac, Siniša Skočibušić, et al.
Vaccine (2024) Vol. 42, Iss. 15, pp. 3467-3473
Open Access | Times Cited: 1
Conservation of HLA Spike Protein Epitopes Supports T Cell Cross-Protection in SARS-CoV-2 Vaccinated Individuals against the Potentially Zoonotic Coronavirus Khosta-2
Antonio J. Martín-Galiano, Daniel López
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6087-6087
Open Access | Times Cited: 1
Antonio J. Martín-Galiano, Daniel López
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6087-6087
Open Access | Times Cited: 1
Humoral and cellular immunogenicity, effectiveness and safety of COVID-19 mRNA vaccination in patients with pediatric rheumatic diseases: A prospective cohort study
Mohamad Hamad Saied, Joeri W. van Straalen, Sytze de Roock, et al.
Vaccine (2024) Vol. 42, Iss. 5, pp. 1145-1153
Open Access
Mohamad Hamad Saied, Joeri W. van Straalen, Sytze de Roock, et al.
Vaccine (2024) Vol. 42, Iss. 5, pp. 1145-1153
Open Access
COVID-19 vaccination and major cardiovascular and haematological adverse events in Abu Dhabi: retrospective cohort study
Marco A. F. Pimentel, Maaz Shaikh, Muna Al Safi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Marco A. F. Pimentel, Maaz Shaikh, Muna Al Safi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
An overview of SARS-CoV-2 viral proteins with relevance to improved diagnostic and therapeutic platforms
Christopher Chung, Pratiba Irudayaraj, Emran O. Lallow, et al.
Frontiers in Virology (2024) Vol. 4
Open Access
Christopher Chung, Pratiba Irudayaraj, Emran O. Lallow, et al.
Frontiers in Virology (2024) Vol. 4
Open Access
Optimizing protocols for the 919 strain-based bovine ephemeral fever virus vaccine (Ultravac®, Zoetis™): Evaluation of dose-dependent effectiveness and long-term immunity
Dan Gleser, Michal Cohen, Gabriel Kenigswald, et al.
Vaccine (2024) Vol. 43, pp. 126531-126531
Closed Access
Dan Gleser, Michal Cohen, Gabriel Kenigswald, et al.
Vaccine (2024) Vol. 43, pp. 126531-126531
Closed Access
Inactivated COVID-19 vaccination and SARS-CoV-2 infection among Chinese adults in the “living with COVID” era
Hongbiao Chen, Siyu Chen, Lei Liu, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e25803-e25803
Open Access
Hongbiao Chen, Siyu Chen, Lei Liu, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e25803-e25803
Open Access
Biases in COVID-19 vaccine effectiveness studies using cohort design
Suneth Agampodi, Birkneh Tilahun Tadesse, Sushant Sahastrabuddhe, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Suneth Agampodi, Birkneh Tilahun Tadesse, Sushant Sahastrabuddhe, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
How well do different COVID-19 vaccines protect against different viral variants? A systematic review and meta-analysis
Hoang Thi Ngoc Anh, Aisling Byrne, Ha‐Linh Quach, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene (2024)
Open Access
Hoang Thi Ngoc Anh, Aisling Byrne, Ha‐Linh Quach, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene (2024)
Open Access